Titan Medical Completes $25 Million Financing to Advance Development and Commercialization of SPORT Single-Port Robotic Surgical System

VCBeat (WeChat Official Account: vcbeat) has learned that medical device company Titan Medical announced on March 21 the completion of a $25 million public offering. Titan Medical stated that the offering included the full exercise of an over-allotment option. Through this option, the company will issue an additional 1.1 million shares at approximately $3.8 million, bringing the total funds raised to approximately $28.8 million. The proceeds from the financing will be used for the design, development, and commercialization of the company’s SPORT Surgical System, as well as for general corporate purposes.

Patient Cart and Camera Insertion Tube (CIT) (Image from the official website)

Titan Medical, headquartered in Toronto, Canada, announced that its initial public offering sold approximately 7.4 million new shares at a price of $3.40 per share. Each new share consists of one common share and one warrant to purchase an additional common share at $4.00 per share. The warrants will expire on March 20, 2024. The shares sold in this financing round are listed on the Toronto Stock Exchange under the symbol “TMD” and traded on the Nasdaq Capital Market under the symbol “TMDI.”

Titan Medical, established in 2008, is a publicly traded medical device company dedicated to the design, development, and commercialization of the SPORT Single-Port Robotic Surgical System for minimally invasive surgery (MIS). The system aims to address the clinical, operational, and financial limitations of robotic platforms in the high-growth robotic surgery market. Current robotic technologies are prohibitively expensive for secondary and tertiary hospitals as well as ambulatory surgical centers, and are limited to a few procedures such as hysterectomies and prostatectomies. Titan’s SPORT Surgical System will expand robotic surgery in a cost-effective manner to currently underserved areas, including general abdominal, gynecological, urological, and colorectal surgeries.

 Open Workstation (Image from Official Website)

The SPORT Surgical System is a versatile, single-port advanced robotic surgical system. It consists of a surgeon-controlled patient cart equipped with multi-jointed instruments for performing minimally invasive surgery (MIS) procedures and a 3D high-definition flat-panel display for visualization. The system features an ergonomic open console and supports a broad range of applications in both single-quadrant and multi-quadrant surgeries. Inspired by direct feedback from laparoscopic surgeons, robotic system users, and other surgical professionals, the SPORT Surgical System offers lower operating costs and superior clinical capabilities compared to previous robotic surgical systems.

Titan Medical has expressed its hope to launch the FDA Investigational Device Exemption (IDE) trial for its SPORT robotic surgical platform before the fourth quarter of this year. Currently, Europe and the United States are the world’s two largest markets for robotic surgery, and Titan plans to commercialize the SPORT surgical system sequentially in Europe and then in the United States.

(Compiled by Li Chengping)